Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
CONCLUSION: Results suggest that vortioxetine is a safe and effective switch therapy for treating SSRI-induced sexual dysfunction in adults with well-treated MDD. Also, improvement in sexual dysfunction with vortioxetine or escitalopram may be influenced by prior SSRI usage, sex, age, and history of MDEs.
PMID: 31010445 [PubMed - as supplied by publisher]
Source: CNS Spectrums - Category: Neurology Authors: Jacobsen PL, Nomikos GG, Zhong W, Cutler AJ, Affinito J, Clayton A Tags: CNS Spectr Source Type: research
More News: Celexa | Citalopram | Depression | Lexapro | Neurology | Paroxetine | Paxil | Sertraline | Sexual Dysfunction | Study | Women | Zoloft